TXG - 10x Genomics, Inc.
21.64
-0.730 -3.373%
Share volume: 1,873,589
Last Updated: 03-05-2026
Measuring And Control Equipment/Lab Analytical Instruments:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$22.37
-0.73
-0.03%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 02-12-2025 | 05-08-2025 | 11-06-2025 | 02-12-2026 | |
| Total revenue | 165.021 M | 154.883 M | 149.002 M | 166.030 M | |
| Cost of revenue | 54.066 M | 49.438 M | 48.695 M | 52.985 M | |
| Gross profit | 110.955 M | 105.445 M | 100.307 M | 113.045 M | |
| -4.97% | -4.87% | 12.70% | |||
| Operating expenses | 160.794 M | 153.973 M | 132.549 M | 132.586 M | |
| Selling general and admin | 93.826 M | 89.728 M | 75.355 M | 76.617 M | |
| Research and development | 66.968 M | 64.245 M | 57.194 M | 55.969 M | |
| Total expenses | 160.794 M | 144.773 M | 132.549 M | 132.586 M | |
| -9.96% | -8.44% | 0.03% | |||
| Operating income | -49.839 M | -39.328 M | -32.242 M | -19.541 M | |
| Ebit | -52.406 M | -37.192 M | -33.407 M | -22.085 M | |
| Pretax income | -48.380 M | -33.506 M | -28.205 M | -15.193 M | |
| -30.74% | -15.82% | -46.13% | |||
| Income tax | 648.000 K | 852.000 K | -733.000 K | 1.059 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -49.028 M | -34.358 M | -27.472 M | -16.252 M | |
| 29.92% | 20.04% | 40.84% |